Literature DB >> 29950149

Field evaluation of onsite near real-time monitors for surface contamination by 5-fluorouracil.

Jerome P Smith1, Deborah Sammons1, Shirley Robertson1, Edward Krieg1, John Snawder1.   

Abstract

OBJECTIVES: In order to produce near real-time onsite results to detect surface contamination by antineoplastic drugs, the National Institute for Occupational Safety and Health developed monitors for 5-fluorouracil, which use surface wiping and lateral flow immunoassay for measurement. The monitors were tested in the laboratory to assess the sensitivity of detection on laboratory-produced contaminated surfaces. A field evaluation to assess the capability of the monitors to make measurements in healthcare workplaces was carried out in collaboration with a medical device company and the results are presented in this report.
METHODS: The 5-fluorouracil monitor was evaluated in areas where oncology drugs were prepared and administered to patients at five different hospitals. The levels of contamination measured with the monitors were compared to levels measured with liquid chromatography-tandem mass spectrometry.
RESULTS: The 5-fluorouracil values measured with the liquid chromatography-tandem mass spectrometry ranged from 0 to over 200,000 ng/100 cm2. Measurements by the 5-fluorouracil monitors in the range 10-100 ng/100 cm2 correlated with the liquid chromatography-tandem mass spectrometry. Receiver operating characteristic curves developed for the data indicated that a positive limit of 22 ng/100 cm2 would give an acceptable level of false-positives while retaining most true-positive samples. If the liquid chromatography-tandem mass spectrometry measured greater than 100 ng/100 cm2, then the monitors also measured levels greater than 100 ng/100 cm2 for the majority of samples.
CONCLUSION: The data indicate that there are many areas in hospitals that are contaminated with 5-fluorouracil and the monitors will be useful in identifying this contamination.

Entities:  

Keywords:  5-fluorouracil; direct reading; surface contamination

Mesh:

Substances:

Year:  2018        PMID: 29950149      PMCID: PMC7899212          DOI: 10.1177/1078155218783538

Source DB:  PubMed          Journal:  J Oncol Pharm Pract        ISSN: 1078-1552            Impact factor:   1.809


  23 in total

1.  Evaluation of antineoplastic drug exposure of health care workers at three university-based US cancer centers.

Authors:  Thomas H Connor; D Gayle DeBord; Jack R Pretty; Marc S Oliver; Tracy S Roth; Peter S J Lees; Edward F Krieg; Bonnie Rogers; Carmen P Escalante; Christine A Toennis; John C Clark; Belinda C Johnson; Melissa A McDiarmid
Journal:  J Occup Environ Med       Date:  2010-10       Impact factor: 2.162

2.  Sampling and mass spectrometric analytical methods for five antineoplastic drugs in the healthcare environment.

Authors:  Jack R Pretty; Thomas H Connor; Ivan Spasojevic; Kristine S Kurtz; Jeffrey L McLaurin; Clayton B'Hymer; D Gayle Debord
Journal:  J Oncol Pharm Pract       Date:  2010-12-23       Impact factor: 1.809

3.  Evaluation of surface contamination in a hospital hematology--oncology pharmacy.

Authors:  Karine Touzin; Jean-François Bussières; Eric Langlois; Michel Lefebvre
Journal:  J Oncol Pharm Pract       Date:  2008-09-04       Impact factor: 1.809

4.  Application and assessment of a regular environmental monitoring of the antineoplastic drug contamination level in pharmacies - the MEWIP project.

Authors:  Thekla K Kiffmeyer; Jochen Tuerk; Moritz Hahn; Hartmut Stuetzer; Claudia Hadtstein; André Heinemann; Udo Eickmann
Journal:  Ann Occup Hyg       Date:  2012-11-02

5.  Determination of the external contamination and cross-contamination by cytotoxic drugs on the surfaces of vials available on the Swiss market.

Authors:  Sandrine Fleury-Souverain; Susanne Nussbaumer; Marc Mattiuzzo; Pascal Bonnabry
Journal:  J Oncol Pharm Pract       Date:  2013-05-14       Impact factor: 1.809

6.  Validation of an HPLC-MS/MS and wipe procedure for mitomycin C contamination.

Authors:  Clayton B'Hymer; Thomas Connor; Derek Stinson; Jack Pretty
Journal:  J Chromatogr Sci       Date:  2014-08-16       Impact factor: 1.618

7.  Multicenter study of environmental contamination with antineoplastic drugs in 36 Canadian hospitals: a 2013 follow-up study.

Authors:  M Berruyer; C Tanguay; N J Caron; M Lefebvre; J F Bussières
Journal:  J Occup Environ Hyg       Date:  2015       Impact factor: 2.155

Review 8. 

Authors:  Céline Poupeau; Christel Roland; Jean-François Bussières
Journal:  Can J Hosp Pharm       Date:  2016-10-31

9.  A new, validated wipe-sampling procedure coupled to LC-MS analysis for the simultaneous determination of 5-fluorouracil, doxorubicin and cyclophosphamide in surface contamination.

Authors:  Christine Bobin-Dubigeon; Marie Amiand; Christelle Percheron; Christelle Audeval; Sophie Rochard; Pierre Leynia; Jean-Marie Bard
Journal:  J Anal Toxicol       Date:  2013-07-04       Impact factor: 3.367

10.  Occupational dermal exposure to cyclophosphamide in Dutch hospitals: a pilot study.

Authors:  Wouter Fransman; Roel Vermeulen; Hans Kromhout
Journal:  Ann Occup Hyg       Date:  2004-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.